Transforming canagliflozin solubility using lipidic carrier and its pharmacokinetic study
{{output}}
The European Medicine Agency has approved canagliflozin (CGF) drug to improve glycemic control in patients with type II diabetes. Our study aimed to enhance the solubility and pharmacokinetics of canagliflozin. Since crystalline canagliflozin is insoluble in w... ...
